BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10557076)

  • 21. Differential expression of MHC class II molecules in highly metastatic breast cancer cells is mediated by the regulation of the CIITA transcription Implication of CIITA in tumor and metastasis development.
    Shi B; Vinyals A; Alia P; BroceƱo C; Chen F; Adrover M; Gelpi C; Price JE; Fabra A
    Int J Biochem Cell Biol; 2006; 38(4):544-62. PubMed ID: 16343978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two distinct gamma interferon-inducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by STAT1, interferon regulatory factor 1, and transforming growth factor beta.
    Piskurich JF; Linhoff MW; Wang Y; Ting JP
    Mol Cell Biol; 1999 Jan; 19(1):431-40. PubMed ID: 9858567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psoriatic lesional skin exhibits an aberrant expression pattern of interferon regulatory factor-2 (IRF-2).
    van der Fits L; van der Wel LI; Laman JD; Prens EP; Verschuren MC
    J Pathol; 2003 Jan; 199(1):107-14. PubMed ID: 12474233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential selectivity of CIITA promoter activation by IFN-gamma and IRF-1 in astrocytes and macrophages: CIITA promoter activation is not affected by TNF-alpha.
    Nikcevich KM; Piskurich JF; Hellendall RP; Wang Y; Ting JP
    J Neuroimmunol; 1999 Oct; 99(2):195-204. PubMed ID: 10505975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon regulatory factor-2 point mutations in human pancreatic tumors.
    Xi H; Blanck G
    Int J Cancer; 2000 Sep; 87(6):803-8. PubMed ID: 10956389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased binding of IFN regulating factor 1 mediates the synergistic induction of CIITA by IFN-gamma and tumor necrosis factor-alpha in human thyroid carcinoma cells.
    Rahat MA; Chernichovski I; Lahat N
    Int Immunol; 2001 Nov; 13(11):1423-32. PubMed ID: 11675374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoter.
    Chen H; Gilbert CA; Hudson JA; Bolick SC; Wright KL; Piskurich JF
    Mol Immunol; 2007 Feb; 44(6):1461-70. PubMed ID: 16765445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MHC class II transactivator (CIITA) expression is upregulated in multiple myeloma cells by IFN-gamma.
    Zhao M; Flynt FL; Hong M; Chen H; Gilbert CA; Briley NT; Bolick SC; Wright KL; Piskurich JF
    Mol Immunol; 2007 Apr; 44(11):2923-32. PubMed ID: 17300840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of a cell-cycle-regulated histone gene by the oncogenic transcription factor IRF-2.
    Vaughan PS; Aziz F; van Wijnen AJ; Wu S; Harada H; Taniguchi T; Soprano KJ; Stein JL; Stein GS
    Nature; 1995 Sep; 377(6547):362-5. PubMed ID: 7566094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon regulatory factor 1 (IRF-1) and IRF-2 distinctively up-regulate gene expression and production of interleukin-7 in human intestinal epithelial cells.
    Oshima S; Nakamura T; Namiki S; Okada E; Tsuchiya K; Okamoto R; Yamazaki M; Yokota T; Aida M; Yamaguchi Y; Kanai T; Handa H; Watanabe M
    Mol Cell Biol; 2004 Jul; 24(14):6298-310. PubMed ID: 15226432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon regulatory factor (IRF)-2 activates the HPV-16 E6-E7 promoter in keratinocytes.
    Lace MJ; Anson JR; Haugen TH; Turek LP
    Virology; 2010 Apr; 399(2):270-9. PubMed ID: 20129639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of the secretory leukocyte protease inhibitor (SLPI) as a target of IRF-1 regulation.
    Nguyen H; Teskey L; Lin R; Hiscott J
    Oncogene; 1999 Sep; 18(39):5455-63. PubMed ID: 10498899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repression of IFN-gamma induction of class II transactivator: a role for PRDM1/Blimp-1 in regulation of cytokine signaling.
    Tooze RM; Stephenson S; Doody GM
    J Immunol; 2006 Oct; 177(7):4584-93. PubMed ID: 16982896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of the lysyl oxidase gene as target of the antioncogenic transcription factor, IRF-1, and its possible role in tumor suppression.
    Tan RS; Taniguchi T; Harada H
    Cancer Res; 1996 May; 56(10):2417-21. PubMed ID: 8625321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. All-trans retinoic acid induces XAF1 expression through an interferon regulatory factor-1 element in colon cancer.
    Wang J; Peng Y; Sun YW; He H; Zhu S; An X; Li M; Lin MC; Zou B; Xia HH; Jiang B; Chan AO; Yuen MF; Kung HF; Wong BC
    Gastroenterology; 2006 Mar; 130(3):747-58. PubMed ID: 16530516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of HLA class I gene transcription in choriocarcinoma cells is controlled by the proximal promoter element and can be reversed by CIITA.
    Lefebvre S; Moreau P; Dausset J; Carosella ED; Paul P
    Placenta; 1999 May; 20(4):293-301. PubMed ID: 10329350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetics of a gamma interferon response: expression and assembly of CIITA promoter IV and inhibition by methylation.
    Morris AC; Beresford GW; Mooney MR; Boss JM
    Mol Cell Biol; 2002 Jul; 22(13):4781-91. PubMed ID: 12052885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Smad3 protein is involved in TGF-beta inhibition of class II transactivator and class II MHC expression.
    Dong Y; Tang L; Letterio JJ; Benveniste EN
    J Immunol; 2001 Jul; 167(1):311-9. PubMed ID: 11418665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cloning of an interferon regulatory factor 2 isoform with different regulatory ability.
    Koenig Merediz SA; Schmidt M; Hoppe GJ; Alfken J; Meraro D; Levi BZ; Neubauer A; Wittig B
    Nucleic Acids Res; 2000 Nov; 28(21):4219-24. PubMed ID: 11058120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cooperative activity between HER oncogenes and the tumor suppressor IRF-1 results in apoptosis.
    Kirchhoff S; Hauser H
    Oncogene; 1999 Jun; 18(25):3725-36. PubMed ID: 10391680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.